SciLifeLab PULSE: an International Postdoctoral Program Empowering Future Leaders in Life Sciences
SciLifeLab has received a funding invitation from Marie Skłodowska-Curie Actions COFUND, part of EU’s Horizon Europe, for SciLifeLab PULSE (Program for Future Leaders in Life Science), a comprehensive 5-year postdoctoral program. The program will train 48 future leaders in life sciences with a launch following the final grant decision in fall 2024. Postdocs will be recruited in two calls (January 2025 and 2026), with the first cohort of 24 postdocs starting in October 2025. The program will offer 3-year fellowships hosted by one of nine Swedish universities with secondments at 24 academic and non-academic partners in Sweden and abroad (see all partners below).
“To advance curiosity-driven, innovative, and translational research while also supporting sustainable careers, increased cooperation across sectors is essential. The SciLifeLab postdoc program PULSE, with partners from academia, research infrastructures, research institutes, as well as biotech and medtech companies, will provide a common foundation for future leaders in life sciences, reduce barriers between sectors and regions, and help build strong networks for future collaborations.
This initiative will not only strengthen Sweden as a life science nation but also offer significant individual benefits by enhancing personal development and international career opportunities. We are grateful for the support from Marie Skłodowska-Curie Actions COFUND to our program, and look forward to the official launch of the program on September 1, 2025”, says Mia Phillipson, SciLifeLab Co-Director and Director of the SciLifeLab PULSE program.
Read more: https://lnkd.in/gJAskjZx
--------------------
Implementing partners: Karolinska Institutet, KTH Royal Institute of Technology, Linköping University, Lund University, Stockholm University, Umeå University, University of Gothenburg, Uppsala University, Örebro University, SciLifeLab Drug Discovery & Development
Associated partners: Affibody AB, Akiram Therapeutics, AstraZeneca, Beactica Therapeutics, CoVaRR-Net, Cytiva, EATRIS, EMBL, Human Technopole, The Swedish Association of the Pharmaceutical Industry, LIF, LIPUM AB, Malmö University, MAX IV Laboratory, Orion Pharma, PROSILICO, QureTech Bio AB, RED GLEAD DISCOVERY, RISE Research Institutes of Sweden, Strike Pharma AB, The Swedish Drug Delivery Center (SweDeliver), SwedenBIO, Testa Center, Toleranzia AB, VIB.